Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 5Other hematologic neoplasm 3Breast 3Head & Neck 2Gastrointestinal 2Myeloid 1Gynecologic 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1Neoplasms 1Fatigue 1Breast Neoplasms, Male 1

Interventions

Trastuzumab 692Paclitaxel 678Cyclophosphamide 634Docetaxel 553Capecitabine 467Letrozole 407Carboplatin 392Fulvestrant 377Doxorubicin 330Tamoxifen 288pembrolizumab 270Anastrozole 252Epirubicin 249exemestane 238pertuzumab 226Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Geritol × Breast × Clear all
NCT02950259 2025-12-03

Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

Providence Health & Services

Phase 1 Completed
16 enrolled 10 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00904033 2019-04-23

Calcitriol, Physical Activity, and Bone Health in Cancer Survivors

University of Rochester

Phase 2 Completed
41 enrolled 27 charts
Breast

Breast Neoplasms

NCT00383409 2006-10-03

Multivitamins do Not Improve Radiation Therapy Related Fatigue

Faculdade de Medicina do ABC

Phase 2 Completed
40 enrolled
Breast

Breast Neoplasms, Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡